Obesity Drug Shortage Triggers Frustrations, Workarounds
The glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide for treating formula obesity (Wegovy) had a roaring takeoff a little more than a year ago, with surging patient demand after the US …
Obesity Drug Shortage Triggers Frustrations, Workarounds Read More